Pretoria, 16 August 2026 – The South African Health Products Regulatory Authority (SAHPRA) has initiated the recall of four batches of Enalapril 10mg Arya, a medicine commonly used to treat high blood pressure (hypertension), following the identification of out-of-specification results during post-marketing surveillance inspections. The recall...
Pretoria, 08 July 2026 – The South African Pharmacy Council (SAPC), Health Professions Council of South Africa (HPCSA) and the South African Health Products Regulatory Authority (SAHPRA) hereby warn the public, pharmacies and dispensing medical practitioners against any continued use, prescription and/or dispensing of iDEXIS...
Pretoria, 25 June 2026 - Since its establishment in 2018, the South African Health Products Regulatory Authority has maintained a strong focus on patient safety as a central pillar of its mandate. In terms of the Medicines and Related Substances Act, 1965 (Act 101 of...
The South African Health Products Regulatory Authority (SAHPRA) held the official online launch of the Prescription-Only Medicines (Rx) Section of the SAHPRA Online Medicines Directory. SAHPRA had previously successfully launched the Over-the-Counter (OTC) Online Medicines Directory in June 2022 as the first phase of this initiative. The...
Pretoria, 23 February 2026 – The South African Health Products Regulatory Authority (SAHPRA) has noted the recent Carte Blanche broadcast raising concerns, based on information from a former employee, regarding alleged Good Manufacturing Practice (GMP) non-compliance at Adcock Ingram’s manufacturing facility in Clayville, Johannesburg. SAHPRA wishes...
The South African Health Products Regulatory Authority (SAHPRA) recently hosted the 3rd webinar in our Codeine Care Initiative (CCI) series, focusing on Patient Safety – Codeine’s Place in Pharmaceutical Care. Following our first module, which centred on holistic management for pain, cough, and colds, and the...
